| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GSK 343 |
|---|
| Description | Potent and selective SAM-competitive EZH2 inhibitor (IC50 = 4 nM). Exhibits >60 fold selectivity for EZH2 over EZH1 and a range of other methyltransferases. Decreases H3K27me3 levels in breast cancer cells in vitro. Inhibits proliferation of prostate cancer cell lines in vitro. Purity 98%. MW (observed): 541.69 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[2-(4-methyl-1-piperazinyl)-4-pyridinyl]-1H-indazole-4-carboxamide |
|---|
| Gene, Accession, CAS # | CAS: 1346704-33-3 |
|---|
| Catalog # | 6128/50 |
|---|
| Price | |
|---|
| Order / More Info | GSK 343 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|